Past PSI Events

Conferences

Health Technology Assessment (HTA)

Gothenburg , Sweden
AstraZeneca

This 2-day course will provide an introduction to the methods of health technology assessment.  There will be a focus on how to estimate the costs and benefits of new interventions and analysis undertaken to support decisions about whether new interventions should be funded by health systems.  The first day will include sessions on policy context and basic economic evaluation methods, as well as lectures on health measurement and valuation for HTA, evidence synthesis and decision analysis.  There will also be exercises to confirm participants’ understanding of key concepts. The second day will focus on sharing case studies and discussing key statistical challenges in HTA such as treatment switching, extrapolation, and network meta-analysis.  Attendees will be encouraged to share their own HTA experiences.  

Please click here to view the flyer.

The following topics will be covered:

  • HTA Policy
  • Methods of Economic Evaluation
  • Critical Review of HTA Publications
  • Evidence Synthesis
  • Measuring and Valuing Health
  • HTA Decision Models
  • Industry HTA Case Studies
  • Key Statistical Challenges in HTA

Presenters:

  • Mark Sculpher, Professor of Health Economics and Director of the Programme on Economic Evaluation and Health Technology Assessment at the University of York.
  • Neil Hawkins, Professor of Health Economics and Health Technology Assessment at the University of Glasgow.
  • Jan McKendrick, Senior Director at PRMA Consulting Ltd.
  • Anja Schiel, Senior Advisor and Statistician and the Norwegian Medicines Agency (NoMA)
  • Jonathan Alsop, Director at Numerus.

Course runs from:

Day 1: 09:00 – 17:30 (registration from 8:30)  
Day 2: 09:00 – 15:30 

Registration:

 Registration has now closed.

PSI are holding a limited number of reduced price hotel rooms at Gothia Towers until the 23rd March which will be allocated on a first come first served basis.

Registration costs (includes lunch and refreshments)

 Before 23rd March
 PSI Members £495
 Non-Members £590
 After 23rd March
 PSI Members £595
 Non-Members £690

PSI are holding a limited number of hotel rooms at Gothia Towers on 23rd and 24th April which will be allocated on a first come first served basis. Rooms will be charged at £115 per room per night including breakfast. Please contact psi@mci-group.com to make a reservation.

Scientific Meetings

Health Technology Assessment (HTA)

Gothenburg , Sweden
AstraZeneca

This 2-day course will provide an introduction to the methods of health technology assessment.  There will be a focus on how to estimate the costs and benefits of new interventions and analysis undertaken to support decisions about whether new interventions should be funded by health systems.  The first day will include sessions on policy context and basic economic evaluation methods, as well as lectures on health measurement and valuation for HTA, evidence synthesis and decision analysis.  There will also be exercises to confirm participants’ understanding of key concepts. The second day will focus on sharing case studies and discussing key statistical challenges in HTA such as treatment switching, extrapolation, and network meta-analysis.  Attendees will be encouraged to share their own HTA experiences.  

Please click here to view the flyer.

The following topics will be covered:

  • HTA Policy
  • Methods of Economic Evaluation
  • Critical Review of HTA Publications
  • Evidence Synthesis
  • Measuring and Valuing Health
  • HTA Decision Models
  • Industry HTA Case Studies
  • Key Statistical Challenges in HTA

Presenters:

  • Mark Sculpher, Professor of Health Economics and Director of the Programme on Economic Evaluation and Health Technology Assessment at the University of York.
  • Neil Hawkins, Professor of Health Economics and Health Technology Assessment at the University of Glasgow.
  • Jan McKendrick, Senior Director at PRMA Consulting Ltd.
  • Anja Schiel, Senior Advisor and Statistician and the Norwegian Medicines Agency (NoMA)
  • Jonathan Alsop, Director at Numerus.

Course runs from:

Day 1: 09:00 – 17:30 (registration from 8:30)  
Day 2: 09:00 – 15:30 

Registration:

 Registration has now closed.

PSI are holding a limited number of reduced price hotel rooms at Gothia Towers until the 23rd March which will be allocated on a first come first served basis.

Registration costs (includes lunch and refreshments)

 Before 23rd March
 PSI Members £495
 Non-Members £590
 After 23rd March
 PSI Members £595
 Non-Members £690

PSI are holding a limited number of hotel rooms at Gothia Towers on 23rd and 24th April which will be allocated on a first come first served basis. Rooms will be charged at £115 per room per night including breakfast. Please contact psi@mci-group.com to make a reservation.

Training Courses

Health Technology Assessment (HTA)

Gothenburg , Sweden
AstraZeneca

This 2-day course will provide an introduction to the methods of health technology assessment.  There will be a focus on how to estimate the costs and benefits of new interventions and analysis undertaken to support decisions about whether new interventions should be funded by health systems.  The first day will include sessions on policy context and basic economic evaluation methods, as well as lectures on health measurement and valuation for HTA, evidence synthesis and decision analysis.  There will also be exercises to confirm participants’ understanding of key concepts. The second day will focus on sharing case studies and discussing key statistical challenges in HTA such as treatment switching, extrapolation, and network meta-analysis.  Attendees will be encouraged to share their own HTA experiences.  

Please click here to view the flyer.

The following topics will be covered:

  • HTA Policy
  • Methods of Economic Evaluation
  • Critical Review of HTA Publications
  • Evidence Synthesis
  • Measuring and Valuing Health
  • HTA Decision Models
  • Industry HTA Case Studies
  • Key Statistical Challenges in HTA

Presenters:

  • Mark Sculpher, Professor of Health Economics and Director of the Programme on Economic Evaluation and Health Technology Assessment at the University of York.
  • Neil Hawkins, Professor of Health Economics and Health Technology Assessment at the University of Glasgow.
  • Jan McKendrick, Senior Director at PRMA Consulting Ltd.
  • Anja Schiel, Senior Advisor and Statistician and the Norwegian Medicines Agency (NoMA)
  • Jonathan Alsop, Director at Numerus.

Course runs from:

Day 1: 09:00 – 17:30 (registration from 8:30)  
Day 2: 09:00 – 15:30 

Registration:

 Registration has now closed.

PSI are holding a limited number of reduced price hotel rooms at Gothia Towers until the 23rd March which will be allocated on a first come first served basis.

Registration costs (includes lunch and refreshments)

 Before 23rd March
 PSI Members £495
 Non-Members £590
 After 23rd March
 PSI Members £595
 Non-Members £690

PSI are holding a limited number of hotel rooms at Gothia Towers on 23rd and 24th April which will be allocated on a first come first served basis. Rooms will be charged at £115 per room per night including breakfast. Please contact psi@mci-group.com to make a reservation.

Journal Club

Health Technology Assessment (HTA)

Gothenburg , Sweden
AstraZeneca

This 2-day course will provide an introduction to the methods of health technology assessment.  There will be a focus on how to estimate the costs and benefits of new interventions and analysis undertaken to support decisions about whether new interventions should be funded by health systems.  The first day will include sessions on policy context and basic economic evaluation methods, as well as lectures on health measurement and valuation for HTA, evidence synthesis and decision analysis.  There will also be exercises to confirm participants’ understanding of key concepts. The second day will focus on sharing case studies and discussing key statistical challenges in HTA such as treatment switching, extrapolation, and network meta-analysis.  Attendees will be encouraged to share their own HTA experiences.  

Please click here to view the flyer.

The following topics will be covered:

  • HTA Policy
  • Methods of Economic Evaluation
  • Critical Review of HTA Publications
  • Evidence Synthesis
  • Measuring and Valuing Health
  • HTA Decision Models
  • Industry HTA Case Studies
  • Key Statistical Challenges in HTA

Presenters:

  • Mark Sculpher, Professor of Health Economics and Director of the Programme on Economic Evaluation and Health Technology Assessment at the University of York.
  • Neil Hawkins, Professor of Health Economics and Health Technology Assessment at the University of Glasgow.
  • Jan McKendrick, Senior Director at PRMA Consulting Ltd.
  • Anja Schiel, Senior Advisor and Statistician and the Norwegian Medicines Agency (NoMA)
  • Jonathan Alsop, Director at Numerus.

Course runs from:

Day 1: 09:00 – 17:30 (registration from 8:30)  
Day 2: 09:00 – 15:30 

Registration:

 Registration has now closed.

PSI are holding a limited number of reduced price hotel rooms at Gothia Towers until the 23rd March which will be allocated on a first come first served basis.

Registration costs (includes lunch and refreshments)

 Before 23rd March
 PSI Members £495
 Non-Members £590
 After 23rd March
 PSI Members £595
 Non-Members £690

PSI are holding a limited number of hotel rooms at Gothia Towers on 23rd and 24th April which will be allocated on a first come first served basis. Rooms will be charged at £115 per room per night including breakfast. Please contact psi@mci-group.com to make a reservation.

Webinars

Health Technology Assessment (HTA)

Gothenburg , Sweden
AstraZeneca

This 2-day course will provide an introduction to the methods of health technology assessment.  There will be a focus on how to estimate the costs and benefits of new interventions and analysis undertaken to support decisions about whether new interventions should be funded by health systems.  The first day will include sessions on policy context and basic economic evaluation methods, as well as lectures on health measurement and valuation for HTA, evidence synthesis and decision analysis.  There will also be exercises to confirm participants’ understanding of key concepts. The second day will focus on sharing case studies and discussing key statistical challenges in HTA such as treatment switching, extrapolation, and network meta-analysis.  Attendees will be encouraged to share their own HTA experiences.  

Please click here to view the flyer.

The following topics will be covered:

  • HTA Policy
  • Methods of Economic Evaluation
  • Critical Review of HTA Publications
  • Evidence Synthesis
  • Measuring and Valuing Health
  • HTA Decision Models
  • Industry HTA Case Studies
  • Key Statistical Challenges in HTA

Presenters:

  • Mark Sculpher, Professor of Health Economics and Director of the Programme on Economic Evaluation and Health Technology Assessment at the University of York.
  • Neil Hawkins, Professor of Health Economics and Health Technology Assessment at the University of Glasgow.
  • Jan McKendrick, Senior Director at PRMA Consulting Ltd.
  • Anja Schiel, Senior Advisor and Statistician and the Norwegian Medicines Agency (NoMA)
  • Jonathan Alsop, Director at Numerus.

Course runs from:

Day 1: 09:00 – 17:30 (registration from 8:30)  
Day 2: 09:00 – 15:30 

Registration:

 Registration has now closed.

PSI are holding a limited number of reduced price hotel rooms at Gothia Towers until the 23rd March which will be allocated on a first come first served basis.

Registration costs (includes lunch and refreshments)

 Before 23rd March
 PSI Members £495
 Non-Members £590
 After 23rd March
 PSI Members £595
 Non-Members £690

PSI are holding a limited number of hotel rooms at Gothia Towers on 23rd and 24th April which will be allocated on a first come first served basis. Rooms will be charged at £115 per room per night including breakfast. Please contact psi@mci-group.com to make a reservation.

Careers Meetings

Health Technology Assessment (HTA)

Gothenburg , Sweden
AstraZeneca

This 2-day course will provide an introduction to the methods of health technology assessment.  There will be a focus on how to estimate the costs and benefits of new interventions and analysis undertaken to support decisions about whether new interventions should be funded by health systems.  The first day will include sessions on policy context and basic economic evaluation methods, as well as lectures on health measurement and valuation for HTA, evidence synthesis and decision analysis.  There will also be exercises to confirm participants’ understanding of key concepts. The second day will focus on sharing case studies and discussing key statistical challenges in HTA such as treatment switching, extrapolation, and network meta-analysis.  Attendees will be encouraged to share their own HTA experiences.  

Please click here to view the flyer.

The following topics will be covered:

  • HTA Policy
  • Methods of Economic Evaluation
  • Critical Review of HTA Publications
  • Evidence Synthesis
  • Measuring and Valuing Health
  • HTA Decision Models
  • Industry HTA Case Studies
  • Key Statistical Challenges in HTA

Presenters:

  • Mark Sculpher, Professor of Health Economics and Director of the Programme on Economic Evaluation and Health Technology Assessment at the University of York.
  • Neil Hawkins, Professor of Health Economics and Health Technology Assessment at the University of Glasgow.
  • Jan McKendrick, Senior Director at PRMA Consulting Ltd.
  • Anja Schiel, Senior Advisor and Statistician and the Norwegian Medicines Agency (NoMA)
  • Jonathan Alsop, Director at Numerus.

Course runs from:

Day 1: 09:00 – 17:30 (registration from 8:30)  
Day 2: 09:00 – 15:30 

Registration:

 Registration has now closed.

PSI are holding a limited number of reduced price hotel rooms at Gothia Towers until the 23rd March which will be allocated on a first come first served basis.

Registration costs (includes lunch and refreshments)

 Before 23rd March
 PSI Members £495
 Non-Members £590
 After 23rd March
 PSI Members £595
 Non-Members £690

PSI are holding a limited number of hotel rooms at Gothia Towers on 23rd and 24th April which will be allocated on a first come first served basis. Rooms will be charged at £115 per room per night including breakfast. Please contact psi@mci-group.com to make a reservation.

Upcoming Events

PSI Introduction to Industry Training (ITIT) Course - 2026/2027

An introductory course giving an overview of the pharmaceutical industry and the drug development process as a whole, aimed at those with 1-3 years' experience. It comprises of six 2-day sessions covering a range of topics including Research and Development, Toxicology, Data Management and the Role of a CRO, Clinical Trials, Reimbursement, and Marketing.

Joint PSI/EFSPI Visualisation SIG 'Wonderful Wednesday' Webinars

Our monthly webinar explores examples of innovative data visualisations relevant to our day to day work. Each month a new dataset is provided from a clinical trial or other relevant example, and participants are invited to submit a graphic that communicates interesting and relevant characteristics of the data.

PSI Book Club: The Art of Explanation - Podcast

The Book Club session will discuss a podcast episode where the host of the Power Hour, Adrienne Herbert, chats with Ros about his book, and the secrets that he learned from years of working in high-pressure newsrooms, and the ten elements of a good explanation and the seven steps you need to take to express yourself with clarity and impact.

AIMS SIG - Open-Source Lunch Bites

Our monthly webinar series allows attendees to gain practical knowledge and skills in open-source coding and tools, with a focus on applications in the pharmaceutical industry. This month’s session, “Graphics Basics,” will introduce the fundamentals of producing graphics using the ggplot2 package.

Connecting the False Discovery Rate to Shrunk Estimates

A 1 hour online event, that includes a presentation followed by Q&A. This talk will explore the “replication crisis” in science, focusing on how testing large numbers of hypotheses can lead to false positive findings. It introduces key statistical approaches—False Discovery Rate (FDR) and shrinkage methods—to address this issue, and explains their conceptual foundations and connections. The session will also highlight how these tools can be understood within an empirical-Bayesian framework, linking significance testing with effect size estimation.

PSI Career Young Virtual Event (Q2 2026)

This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.

PSI Book Club: The AI Con – Joint with ASA Book Club

The Guardian described the authors of this book as refreshingly sarcastic! What is sold to us as AI, they announce, is just "a bill of goods": "A few major well-placed players are poised to accumulate significant wealth by extracting value from other people's creative work, personal data, or labour, and replacing quality services with artificial facsimiles."

PSI Book Club: Another Door Opens – Book Club Special Event

This is a Book Club Special Event in response to the changes in our industry and as a supportive move to create community and connection for those navigating redundancy and uncertainty. Read the book in advance of the book club session then join the zoom call to discuss ideas. There will be breakout groups to connect with others, exchange experiences of how the book has helped, and offer support.

PSI Career Young Virtual Event (Q3 2026)

This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.

PSI Career Young Virtual Event (Q4 2026)

This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.

Latest Jobs

Metronomia Clinical Research GmbH - Principal Statistician

Join a motivated and friendly team and help shape Metronomia as a Principal Statistician

GSK - Statistics Director - Vaccines and Infectious Disease

We are seeking an experienced and visionary Statistics Director to join our Team and lead strategic statistical innovation across GSK’s Vaccines and Infectious Disease portfolio.

ICON PLC - Biostatistician II

We are currently seeking a Biostatistician II to join our diverse and dynamic team.

ICON PLC - Principal Biostatistician

As a Principal Biostatistician, you will lead the statistical strategy and delivery for Phase I–III oncology trials.

ICON PLC - Senior Biostatistician

As a Senior Biostatistician I at ICON, you will play a pivotal role in designing and analyzing clinical trials, interpreting complex medical data, and contributing to the advancement of innovative treatments and therapies.

ICON PLC - Statistical Programmer II

As a Statistical Programmer II at ICON, you will play a vital role in the development, validation, and execution of statistical programs to support clinical trial analysis and reporting.

ICON PLC - Statistical Scientist

As a Statistical Scientist at ICON, you will play a pivotal role in designing and analyzing clinical trials, interpreting complex medical data, and contributing to the advancement of innovative treatments and therapies.

Novartis - Associate Director Biostatistics

We have an exciting opportunity for an Associate Director, Biostatistics to join a passionate team within Advanced Quantitative Sciences – Full Development.

Novartis - Associate Director, Statistical Programming

: We have an exciting opportunity for an Associate Director (AD), Statistical Programming, to join a passionate team within Advanced Quantitative Sciences- Development.

Novartis - Principal Statistical Programmer

We have an exciting opportunity for a Principal Statistical Programmer, to join a passionate team within Advanced Quantitative Sciences – Development.

Novartis - Senior Principal Biostatistician

We are in search of a Senior Principal Biostatistician to join a passionate team within Advanced Quantitative Sciences.

Novartis - Senior Principal Statistical Programmer

We have an exciting opportunity for a Senior Principal Statistical Programmer, to join a passionate team within Advanced Quantitative Sciences – Development.

Pierre Fabre - Clinical Development Safety Statistics Expert M/F

We are seeking a highly skilled and proactive Clinical Development Safety Statistics Expert to join our Biometry Department and the Biometry Leadership Team based in Toulouse (31, Oncopole) or Boulogne (92).

Pierre Fabre - Lead Statistician – Real World Evidence -CDI- M/F

Pierre Fabre Laboratories are hiring a highly skilled and experienced Lead Statistician – Real World Evidence (RWE) to join the Biometry Department, part of the Data Science & Biometry Department, based in Toulouse (Oncopôle) or Boulogne.

Pierre Fabre - Lead Statistician- Clinical Trials M/F

We are seeking a highly skilled and experienced Lead Statistician in Clinical Trials to join our Biometry Department based in Toulouse (31, Oncopole) or Boulogne (92).

Plus-Project - Senior Statistician

We currently have openings for Senior Statisticians based in the UK to join our Employee Owned Biostatistics CRO, Plus-Project.

Viatris - Senior Statistician (m/f/d)

As a Senior Statistician at Viatris, you will take a leading role in designing clinical studies, guiding statistical strategy, and ensuring that statistical deliverables meet the highest scientific and regulatory standards.